221 related articles for article (PubMed ID: 30791732)
21. Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: a network meta-analysis of randomized controlled trials.
Liu S; Wu JR; Zhang D; Wang KH; Zhang B; Zhang XM; Tan D; Duan XJ; Cui YY; Liu XK
BMC Complement Altern Med; 2018 Apr; 18(1):120. PubMed ID: 29615027
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy of Chinese herbal injections combined with azithromycin for mycoplasma pneumonia in children: A Bayesian network meta-analysis of randomized controlled trials.
Duan X; Wang K; Wu J; Zhang D; Liu X; Ni M; Liu S; Meng Z
J Clin Pharm Ther; 2019 Oct; 44(5):675-684. PubMed ID: 31119782
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With
Qin S; Li J; Wang L; Xu J; Cheng Y; Bai Y; Li W; Xu N; Lin LZ; Wu Q; Li Y; Yang J; Pan H; Ouyang X; Qiu W; Wu K; Xiong J; Dai G; Liang H; Hu C; Zhang J; Tao M; Yao Q; Wang J; Chen J; Eggleton SP; Liu T
J Clin Oncol; 2018 Oct; 36(30):3031-3039. PubMed ID: 30199311
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of cetuximab combined with chemotherapy as a first-line treatment for patients with RAS wild-type metastatic colorectal cancer based on the TAILOR trial.
Wang H; Huang L; Gao P; Zhu Z; Ye W; Ding H; Fang L
BMJ Open; 2020 Feb; 10(2):e030738. PubMed ID: 32051297
[TBL] [Abstract][Full Text] [Related]
25. The Optimal Chinese Herbal Injections for Use With Radiotherapy to Treat Esophageal Cancer: A Systematic Review and Bayesian Network Meta-Analysis.
Zhang D; Ni M; Wu J; Liu S; Meng Z; Tian J; Zhang X; Zhang B
Front Pharmacol; 2018; 9():1470. PubMed ID: 30662402
[No Abstract] [Full Text] [Related]
26. Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer: A bayesian network meta-analysis of randomized controlled trials.
Peng C; Chen J; Cui W; Li S; Li J; Peng L
Front Pharmacol; 2022; 13():1037620. PubMed ID: 36438813
[No Abstract] [Full Text] [Related]
27. Comparative Efficacy of Tonic Chinese Herbal Injections for Treating Sepsis or Septic Shock: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials.
Xiao L; Niu L; Xu X; Zhao Y; Yue L; Liu X; Li G
Front Pharmacol; 2022; 13():830030. PubMed ID: 35370733
[No Abstract] [Full Text] [Related]
28. Investigation on the Efficiency of Chinese Herbal Injections for Treating Non-small Cell Lung Cancer With Vinorelbine and Cisplatin Based on Multidimensional Bayesian Network Meta-Analysis.
Ni M; Wang H; Wang M; Zhou W; Zhang J; Wu J; Zhang D; Jing Z; Liu X; Wu Z; Guo S; Jia S; Zhang X; Sheng X
Front Pharmacol; 2020; 11():631170. PubMed ID: 33708126
[No Abstract] [Full Text] [Related]
29. Chinese herbal injections for heart failure: A protocol for systematic review and network meta-analyses.
Yang F; Zou J; Ge L; Tian J; Lee MS; Jun JH; Zhang J
Medicine (Baltimore); 2018 Feb; 97(8):e9973. PubMed ID: 29465597
[TBL] [Abstract][Full Text] [Related]
30. Yiqi zhuyu decoction combined with FOLFOX-4 as first-line therapy in metastatic colorectal cancer.
Cao B; Li ST; Li Z; Deng WL
Chin J Integr Med; 2011 Aug; 17(8):593-9. PubMed ID: 21826593
[TBL] [Abstract][Full Text] [Related]
31. Comparative Efficacy of Chinese Herbal Injections Combined with Paclitaxel Plus Cisplatin for Non-Small-Cell Lung Cancer: A Multidimensional Bayesian Network Meta-Analysis.
Ni M; Wang H; Wang M; Zhou W; Wu J; Sun B; Zhang Q; Fan X; Zhang D; Jing Z; Zhang J; Liu X; Liu S; Meng Z; Guo S; Jia S; Zhang X; Sheng X
Evid Based Complement Alternat Med; 2020; 2020():1824536. PubMed ID: 33178307
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Chinese herbal injections combined with fluoropyrimidine and oxaliplatin-based chemotherapy for advanced colorectal cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
Wang S; Wang X; Zhang Y; Zhou T; Hu S; Tian P; Li Z; Li Y; Gui Y; Dong J; Hou W
Medicine (Baltimore); 2020 Dec; 99(52):e23550. PubMed ID: 33350733
[TBL] [Abstract][Full Text] [Related]
33. Oral Chinese Patent Medicine Combined With Oxaliplatin-Based Chemotherapy Regimen for the Treatment of Colorectal Cancer: A Network Meta-Analysis.
Tang M; He B; Zhai J; Wang L
Integr Cancer Ther; 2021; 20():15347354211058169. PubMed ID: 34844475
[TBL] [Abstract][Full Text] [Related]
34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
35. Investigation on the Efficiency of Chinese Herbal Injections combined with Concurrent Chemoradiotherapy for Treating Nasopharyngeal Carcinoma based on Multidimensional Bayesian Network Meta-analysis.
Wu Z; Wang H; Wu J; Guo S; Zhou W; Wu C; Lu S; Wang M; Zhang X; Li J; Tan Y; Fan X; Huang Z
Front Pharmacol; 2021; 12():656724. PubMed ID: 34177576
[No Abstract] [Full Text] [Related]
36. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
[TBL] [Abstract][Full Text] [Related]
37. Traditional Chinese medicine for neonatal hypoxic-ischemic encephalopathy: A Bayesian network meta-analysis.
Zhang C; Guo J; Yin H; Yin C; Peng Y
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117317. PubMed ID: 37832809
[TBL] [Abstract][Full Text] [Related]
38. Second-line systemic therapy for metastatic colorectal cancer.
Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
[TBL] [Abstract][Full Text] [Related]
39. Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.
Zaanan A; Shi Q; Taieb J; Alberts SR; Meyers JP; Smyrk TC; Julie C; Zawadi A; Tabernero J; Mini E; Goldberg RM; Folprecht G; Van Laethem JL; Le Malicot K; Sargent DJ; Laurent-Puig P; Sinicrope FA
JAMA Oncol; 2018 Mar; 4(3):379-383. PubMed ID: 28983557
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
